Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Filings indexed 247 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for Access Bio, Inc. covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, including balance sheets, income statements, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report (RPA) nor a simple certification, as it provides substantive financial data and operational analysis. H1 2025
2025-08-14 Korean
반기또는분기매출액미달사실발생
Earnings Release Classification · 1% confidence The document is a regulatory disclosure from Access Bio regarding a failure to meet minimum quarterly revenue requirements (under 300 million KRW). It provides specific financial data for the second quarter of 2025, including revenue figures and auditor information. Since this is a specific regulatory disclosure regarding financial performance thresholds rather than a full quarterly report or a simple announcement of a report's availability, it falls under the general regulatory filing category. Q2 2025
2025-08-14 Korean
기타시장안내 (상장적격성 실질심사 관련)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice from the KOSDAQ market regarding Access Bio's eligibility for continued listing due to a failure to meet quarterly revenue requirements. It is a formal regulatory announcement concerning listing status and compliance, which fits the definition of a general regulatory filing (RNS) as it does not constitute a full legal proceeding report or a specific financial report.
2025-08-14 Korean
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Delisting Announcement Classification · 1% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for Access Bio due to a review of listing eligibility ('상장적격성 실질심사 대상'). This is a regulatory announcement issued by the exchange, which does not fit into specific categories like earnings or dividends, and is best classified as a general regulatory filing.
2025-08-14 Korean
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Stock Option Grant) which has been amended (정정신고). It details the cancellation of previously granted stock options for the CEO. In the context of financial filings, announcements regarding the issuance, modification, or cancellation of stock options or capital-related instruments are classified as 'Share Issue/Capital Change' (SHA) as they directly impact the company's capital structure and equity obligations.
2025-05-20 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company Access Bio, covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial statements, notes to financial statements, management discussion and analysis, and other required disclosures for a quarterly filing. This fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.